Browse drugs

…nicity and recent disease activity increased renal risks, while antimalarials were protective. GCs showed mixed effects. Item-specific strate…

…depending on availability at health facilities. Antibiotics and antipyretics were the most commonly prescribed treatments. The healthcare pr…

…e the most common characteristic related to accumulated damage. Glucocorticoids, antimalarials and immunosuppressants were the most commonly us…

…d with other systemic manifestations, except in two cases where rituximab was required for refractory thrombocytopenia.Conclusions Thromb…

…sits to the clinic over longer follow-ups, with higher doses of glucocorticoids and antimalarials, higher disease activity, irreversible damage…

…and 4%-13%, respectively); biologic use was primarily off-label rituximab.…

… anxiety (13.9%). Participants’ current CLE treatments included antimalarials (69.7%), topical corticosteroids (50.8%), and immunosuppressant…

…uppressants (off-treatment; n = 244), AM monotherapy (n = 198), GC monotherapy (n = 45), or AM and GC combined therapy but no immu…

…bodies in 73.2%.Regarding treatment, 85.1% of patients received antimalarials and 95.8% systemic corticosteroids. Conventional immunosuppress…

…uration, depression (BDI-II), anxiety (BAI), and current use of glucocorticoids, antimalarials, immunosuppressants, or biologics. Multilevel Ba…